Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accuredit, Bio-Thera, Carsgen, Eisai, Experimental Drug Development Centre, Henlius, Jiangsu Hengrui, Junshi, Otsuka, Remegen, Samsung Bioepis, Teva.